Skip to content

Clinical trials

Schizophrenia trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Not applicable Country / region: Canada Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20042
20062
20072
20083
20093
20102
20112
20124
20134
20141
20153
20167
20174
20182
20197
20205
20216
20224
20238
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting13
Unknown status6
Terminated5
Active, not recruiting4
Withdrawn2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health40
University of Toronto6
The Royal Ottawa Mental Health Centre5
Douglas Mental Health University Institute4
Ciusss de L'Est de l'Île de Montréal3
Nova Scotia Health Authority3
Queen's University2
University of Alberta2
University of British Columbia2
University of Ottawa2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia81
Psychotic Disorders51
Bipolar Disorder8
Mental Disorders8
Schizophrenia, Treatment-Resistant6
Hallucinations5
Major Depressive Disorder4
Schizophrenia Spectrum and Other Psychotic Disorders4
Cognitive Dysfunction3
Affective Disorders, Psychotic2

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.